{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T14:27:27Z","timestamp":1781274447238,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1038\/sj.bjc.66000524","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T10:59:25Z","timestamp":1032346765000},"page":"729-732","source":"Crossref","is-referenced-by-count":27,"title":["Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group"],"prefix":"10.1038","volume":"87","author":[{"given":"C","family":"Kollmannsberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Rick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Klaproth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H G","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hentrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Welslau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Spott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,9,23]]},"reference":[{"key":"BF6600524_CR1","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1200\/JCO.1996.14.10.2638","volume":"14","author":"J Beyer","year":"1996","unstructured":"Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W (1996) High-dose chemotherapy as salvage treatment in germ cell tumours: A multivariate analysis of prognostic variables. J Clin Oncol 14: 2638\u20132645","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/oxfordjournals.annonc.a010473","volume":"7","author":"C Bokemeyer","year":"1996","unstructured":"Bokemeyer C, Beyer J, Metzner B, R\u00fcther U, Harstrick A, Wei\u00dfbach L, K\u00f6hrmann U, Verbeek W, Schmoll HJ (1996) Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 7: 31\u201334","journal-title":"Ann Oncol"},{"key":"BF6600524_CR3","first-page":"29","volume":"16","author":"C Bokemeyer","year":"1993","unstructured":"Bokemeyer C, Droz JP, Hanauske A, Schr\u00f6der M, Quei\u00dfer W, Schmoll HJ (1993) Treatment of relapsed nonseminomatous germ cell tumours with vinorelbine: A trial of the phase I\/II study group of the Association of Medical Oncology of the German Cancer Society. Onkologie 16: 29\u201331","journal-title":"Onkologie"},{"key":"BF6600524_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1200\/JCO.1999.17.2.512","volume":"17","author":"C Bokemeyer","year":"1999","unstructured":"Bokemeyer C, Gerl A, Sch\u00f6ffski P, Harstrick A, Niederle N, Beyer J, Casper J, Schmoll HJ, Kanz L (1999) Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 17: 512\u2013516","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJM199707243370406","volume":"337","author":"GJ Bosl","year":"1997","unstructured":"Bosl GJ, Motzer RJ (1997) Medical progress: Testicular germ-cell cancer. N Engl J Med 337: 242\u2013253","journal-title":"N Engl J Med"},{"key":"BF6600524_CR6","first-page":"89a","volume":"17","author":"M Bregni","year":"1998","unstructured":"Bregni M, Marzola M, DiNicola M, Bonazzi C, Siena S, Cantu MG, Matteucci P, Lissoni A, Magni M, Miceli D, Devizzi L, Vecchione F, Gianni AM (1998) Full-dose conventional chemotherapy is feasible and effective after tandem high-dose chemotherapy supported by mobilized blood autografting. Proc Am Soc Clin Oncol 17: 89a (abstract 342)","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"suppl. 1","key":"BF6600524_CR7","first-page":"57","volume":"21","author":"M Constenla","year":"1998","unstructured":"Constenla M, Lorenzo I, Garcia Arroyo FR, Rey C, Carrete N (1998) Taxane treatment of relapsed breast cancer after high-dose chemotherapy & autologous PBPC-transplantation. Bone Marrow Transplant 21(suppl. 1): 57","journal-title":"Bone Marrow Transplant"},{"key":"BF6600524_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0305-7372(94)90011-6","volume":"20","author":"GJ Creemers","year":"1994","unstructured":"Creemers GJ, Lund B, Verweij J (1994) Topoisomerase I inhibitors: topotecan and irenotecan. Cancer Treat Rev 20: 73\u201396","journal-title":"Cancer Treat Rev"},{"key":"BF6600524_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(98)02309-5","volume":"352","author":"D Cunningham","year":"1998","unstructured":"Cunningham D, Pyrhonen S, James RD, Punt CJ, Hickish TF, Heikkila R, Johannesen TB, Starkhammar H, Topham CA, Awad L, Jacques C, Herait P (1998) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352: 1413\u20131418","journal-title":"Lancet"},{"key":"BF6600524_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","volume":"355","author":"JY Douillard","year":"2000","unstructured":"Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J, Alakl M, Gruia G, Awad L, Rougier P (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355: 1041\u20131047","journal-title":"Lancet"},{"key":"BF6600524_CR11","first-page":"863","volume":"71","author":"RE Drasga","year":"1987","unstructured":"Drasga RE, Williams S, Einhorn LH, Birch R (1987) Phase II evaluation of iproplatin in refractory germ cell tumours: A Southeastern Cancer Study Group trial. Cancer Treat Rep 71: 863\u2013864","journal-title":"Cancer Treat Rep"},{"key":"BF6600524_CR12","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1200\/JCO.1990.8.11.1777","volume":"8","author":"LH Einhorn","year":"1990","unstructured":"Einhorn LH (1990) Treatment of testicular cancer: A new and improved model. J Clin Oncol 8: 1777\u20131781","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1200\/JCO.1999.17.2.509","volume":"17","author":"LH Einhorn","year":"1999","unstructured":"Einhorn LH, Stender MJ, Williams SD (1999) Phase II trial of gemcitabine in refractory germ cell tumours. J Clin Oncol 17: 509\u2013511","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","volume":"13","author":"E Gehan","year":"1961","unstructured":"Gehan E (1961) The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chron Dis 13: 346\u2013353","journal-title":"J Chron Dis"},{"key":"BF6600524_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00001813-200008000-00003","volume":"11","author":"C Kollmannsberger","year":"2000","unstructured":"Kollmannsberger C, Gerl A, Schleucher N, Beyer J, Rick O, Casper J, Sosada M, Kanz L, Bokemeyer C (2000) Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer. Anticancer Drugs 11: 535\u2013539","journal-title":"Anticancer Drugs"},{"key":"BF6600524_CR16","first-page":"193a","volume":"20","author":"C Kollmannsberger","year":"2001","unstructured":"Kollmannsberger C, Rick O, Beyer J, Derigs H-G, Mayer F, Schleucher N, Schoeffski P, Sosada M, Spott C, Kanz L, Bokemeyer C (2001) Oxaliplatin in patients (pts) with cisplatin-refractory germ cell cancer (GCT). Proc Am Soc Clin Oncol 20: 193a (abstract 770)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600524_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000474425","volume":"31","author":"T Miki","year":"1997","unstructured":"Miki T, Sawada M, Nonomura N, Kojima Y, Okuyama A, Maeda O, Saiki S, Kotake T (1997) Antitumour effect of CPT\u201311, a camptothecin derivative, on human testicular tumour xenografts in nude mice. Eur Urol 31: 92\u201396","journal-title":"Eur Urol"},{"key":"BF6600524_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoodgstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207\u2013211","journal-title":"Cancer"},{"key":"BF6600524_CR19","first-page":"36","volume":"17","author":"JC Miller","year":"1990","unstructured":"Miller JC, Einhorn LH (1990) Phase II study of daily oral etoposide in refractory germ cell tumours. Semin Oncol 17: 36\u201339","journal-title":"Semin Oncol"},{"key":"BF6600524_CR20","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1200\/JCO.1994.12.11.2277","volume":"12","author":"RJ Motzer","year":"1994","unstructured":"Motzer RJ, Bajorin D, Schwartz LH, Hutter HS, Bosl GJ, Scher H, Lyn P, Fischer P (1994) Phase II trial of paclitaxel shows antitumour activity in patients with previously treated germ cell tumours. J Clin Oncol 12: 2277\u20132283","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR21","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1200\/JCO.2000.18.12.2413","volume":"18","author":"RJ Motzer","year":"2000","unstructured":"Motzer RJ, Sheinfeld J, Mazumdar M, Bains M, Mariani T, Bacik J, Bajorin D, Bosl G (2000) Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 18: 2413\u20132418","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF00944190","volume":"10","author":"B Murphy","year":"1992","unstructured":"Murphy B, Motzer RJ, Bosl GJ (1992) Phase II study of iproplatin (CHIP) in patients with cisplatin-refractory germ cell tumours; the need for alternative strategies in the investigation of new agents in GCT. Invest New Drugs 10: 327\u2013330","journal-title":"Invest New Drugs"},{"issue":"suppl 12","key":"BF6600524_CR23","first-page":"102","volume":"5","author":"CR Nichols","year":"1994","unstructured":"Nichols CR, Roth BJ, Loehrer PJ, Williams SD, Einhorn LH (1994) Salvage chemotherapy for recurrent germ cell cancer. Semin Oncol 5(suppl 12): 102\u2013108","journal-title":"Semin Oncol"},{"key":"BF6600524_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1200\/JCO.1989.7.7.932","volume":"7","author":"CR Nichols","year":"1989","unstructured":"Nichols CR, Tricot G, Williams SD, van Besien K, Loehrer PJ, Roth BJ, Akard L, Hoffman R, Goulet R, Wolff SN, Giannone L, Greer J, Einhorn LH, Jansen J (1989) Dose-intensive chemotherapy in refractory germ cell cancer \u2013 a phase I\/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7: 932\u2013939","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR25","first-page":"351a","volume":"19","author":"T Nomoto","year":"2000","unstructured":"Nomoto T, Miki T, Nakao M, Mizutani Y, Nakagawa S, Nakamura T, Nonomura N, Okuyama A, Saiki S, Kotake T (2000) Salvage chemotherapy with CPT-11 and cisplatin for cisplatin-refractory germ cell cancer. Proc Am Soc Clin Oncol 19: 351a (abstract 1383)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600524_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1200\/JCO.2000.18.6.1181","volume":"18","author":"P Porcu","year":"2000","unstructured":"Porcu P, Bhatia S, Einhorn LH (2000) Results of treatment after relapse from high-dose chemotherapy in germ cell tumours. J Clin Oncol 18: 1181\u20131186","journal-title":"J Clin Oncol"},{"key":"BF6600524_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00872866","volume":"13","author":"HS Puc","year":"1995","unstructured":"Puc HS, Bajorin D, Bosl GJ, Amsterdam A, Motzer RJ (1995) Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumours. Invest New Drugs 13: 163\u2013165","journal-title":"Invest New Drugs"},{"key":"BF6600524_CR28","first-page":"46","volume":"15","author":"CM Rocha-Lima","year":"2001","unstructured":"Rocha-Lima CM, Sherman CA, Brescia FJ, Brunson CY, Green MR (2001) Irinotecan\/gemcitabine combination chemotherapy in pancreatic cancer. Oncology (Huntingt) 15: 46\u201351","journal-title":"Oncology (Huntingt)"},{"key":"BF6600524_CR29","first-page":"103","volume":"12","author":"LS Rosen","year":"1998","unstructured":"Rosen LS (1998) Irinotecan in lymphoma, leukemia, and breast, pancreatic, ovarian, and small-cell lung cancers. Oncology (Huntingt) 12: 103\u2013109","journal-title":"Oncology (Huntingt)"},{"key":"BF6600524_CR30","first-page":"174a","volume":"17","author":"C Sola","year":"1999","unstructured":"Sola C, Lluch A, Garcia-Conde J, Ojeda B, Horendo J, Benavides M, Solano C, Garcia-Salazar T, Alonso S, Cortes-Funes H, Lopez JJ (1999) Phase II study of weekly paclitaxel in recurrent breast cancer after high-dose chemotherapy. Proc Am Soc Clin Oncol 17: 174a (abstract 245)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600524_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s002800100316","volume":"48","author":"K Takeda","year":"2001","unstructured":"Takeda K, Negoro S, Takifuji N, Nitta T, Yoshimura N, Terakawa K, Fukuoka M (2001) Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 48: 104\u2013108","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6600524_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1054\/bjoc.2001.1861","volume":"85","author":"H Ueoka","year":"2001","unstructured":"Ueoka H, Tanimoto M, Kiura K, Tabata M, Takigawa N, Segawa Y, Takata I, Eguchi K, Okimoto N, Harita S, Kamei H, Shibayama T, Watanabe Y, Hiraki S, Harada M (2001) Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group. Br J Cancer 85: 9\u201313","journal-title":"Br J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600524","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:44:44Z","timestamp":1684413884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["BF6600524"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.66000524","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}